Chapter 9: Streptococci: Pathogenesis & Clinical Syndromes

Streptococci: Pathogenesis & Clinical Syndromes overview explores the medically significant family of gram-positive, catalase-negative bacteria known as streptococci, which are typically identified by their ovoid shape and tendency to form pairs or chains. These microorganisms are primarily categorized using two major systems: their hemolytic patterns on blood agar—classified as alpha, beta, or gamma—and the Lancefield classification, which groups bacteria based on specific cell wall antigens. Streptococcus pyogenes, the representative for Group A, is a formidable human pathogen that utilizes a hyaluronic acid capsule to remain invisible to the host immune system and highly variable M proteins to facilitate infection. Its clinical impact is broad, ranging from common respiratory infections like pharyngitis and skin conditions like impetigo to severe, rapidly progressing diseases such as necrotizing fasciitis and toxic shock syndrome. Furthermore, this species is notorious for causing serious post-infectious autoimmune complications, including rheumatic fever and kidney damage. The chapter also examines Streptococcus agalactiae, or Group B streptococci, which is a leading cause of life-threatening sepsis and meningitis in newborns. Transitioning to Streptococcus pneumoniae, the text describes this encapsulated diplococcus as a primary agent of community-acquired pneumonia and adult bacterial meningitis, noting the critical role of its polysaccharide capsule in virulence and the effectiveness of modern conjugate vaccines in reducing disease prevalence. Additionally, the Enterococcus genus is discussed, highlighting its evolution from Group D streptococci into a distinct group of resilient organisms often associated with hospital-acquired infections and significant antibiotic resistance, such as vancomycin-resistant strains. Finally, the viridans group is addressed, detailing their role as common oral flora that can lead to dental decay or infective endocarditis in patients with preexisting heart valve issues.